Medicine recalls
|
| |
| Canada: Recall: One lot of Riva-Risperidone 0.25 mg tablets recalled due to a packaging error |
| |
Health Canada announces that Laboratoire Riva Inc. is recalling one lot of Riva-Risperidone 0.25 mg tablets (lot number: C9323) due to a packaging error. Some bottles may incorrectly contain only Riva-Gabapentin 100 mg capsules. Pharmacists may not recognize the error and inadvertently repackage and dispense pill bottles that contain the wrong medication.
Risperidone is a prescription drug used in adults to treat the symptoms of schizophrenia and related psychotic disorders, as well as bipolar disorder. It may also be used for the short-term treatment of severe dementia related to Alzheimer's disease. Gabapentin is a prescription drug used for treating epilepsy (seizures).
If patients miss a dose of risperidone, they may not have proper control of their condition or its symptoms may worsen.
By taking gabapentin instead of risperidone, they may:
- develop serious side effects, such as swelling of the legs, ankles or feet (edema)
- experience side effects, such as agitation, drowsiness, dizziness, lack of muscle coordination and fatigue
If they notice any of these signs or symptoms, contact their health care professional immediately.
Riva-Risperidone 0.25 mg tablets are yellowish-orange, oblong-shaped coated tablets, with "0.25" on one side and "R" on the other side. Riva-Gabapentin 100 mg capsules are white hard gelatin capsules, with "Gabapentin / 100 mg" printed on the capsule in blue ink.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../76619a-eng.php
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Monday, Oct 11, 2021
Issued at HKT 14:00
|
| |
